Clinical Trials Browser

Phase 2 × Unknown × Philadelphia Chromosome × Clear all

NCT01883219 2017-11-08

TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Philadelphia Chromosome, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma